Fennec Pharmaceuticals (FENC) Finished Goods (2022 - 2026)
Fennec Pharmaceuticals' (FENC) quarterly Finished Goods came in at $1.6 million in Q4 2025, up 47.64% YoY from $1.1 million in Q4 2024, and down 36.82% on a QoQ basis from $2.5 million in Q3 2025.
Fennec Pharmaceuticals (FENC) Finished Goods (2022 - 2026) Analysis & Trends
Fennec Pharmaceuticals (FENC) has 4 years of Finished Goods data on file, last reported at $1.6 million in Q4 2025.
- Quarterly Finished Goods rose 47.64% year-over-year to $1.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.6 million (up 47.64% YoY) and the FY2025 annual result came in at $1.6 million, up 47.64% from the prior year.
- Finished Goods eased to $1.6 million in Q4 2025, from $2.5 million in the prior quarter.
- In the past five years, Finished Goods ranged from a high of $2.5 million in Q3 2025 to a low of $576000.0 in Q4 2022.
- A 4-year average of $1.6 million and a median of $1.6 million in 2025 frame the typical range for Finished Goods.
- Annual changes were most pronounced in 2023 — Finished Goods surged 274.31% — and 2024, when it slumped 50.83%.
- Tracing FENC's Finished Goods over 4 years: stood at $576000.0 in 2022, then surged by 274.31% to $2.2 million in 2023, then tumbled by 50.83% to $1.1 million in 2024, then surged by 47.64% to $1.6 million in 2025.
- The last three Finished Goods figures came in at $1.6 million (Q4 2025), $2.5 million (Q3 2025), and $2.2 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fennec Pharmaceuticals | 410.60 Mn | 369.35 Mn | 17.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.37 Mn |
| Dec 31, 2025 | 1.57 Mn |
| Sep 30, 2025 | 2.48 Mn |
| Jun 30, 2025 | 2.20 Mn |
| Mar 31, 2025 | 1.40 Mn |
| Dec 31, 2024 | 1.06 Mn |
| Sep 30, 2024 | 1.13 Mn |
| Jun 30, 2024 | 2.14 Mn |
| Mar 31, 2024 | 2.06 Mn |
| Dec 31, 2023 | 2.16 Mn |
| Sep 30, 2023 | 1.76 Mn |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 918,000.00 |
| Dec 31, 2022 | 576,000.00 |